English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
×
Site Menu
Home
Local
Politics
World
Finance
Sports
Entertainment
Lifestyle
Technology
Science
Weather
Android app
Help
English
German (DE)
English (US)
Spanish (ES)
French (FR)
Hindi (IN)
Italian (IT)
Russian (RU)
Jim Cramer Expresses Shock Over Paychex Stock’s 9% Decline
Jim Cramer on DocuSign Stock: “It’s Time to Sell”
Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”
Jim Cramer Calls Marvell’s Recent Sell Rating “Ridiculous”
Previous
Next
Your briefing
Jim Cramer Expresses Shock Over Paychex Stock’s 9% Decline
Jim Cramer Expresses Shock Over Paychex Stock’s 9% Decline
Share this via
Full Coverage
Jim Cramer on DocuSign Stock: “It’s Time to Sell”
Jim Cramer on DocuSign Stock: “It’s Time to Sell”
Share this via
Full Coverage
Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”
Jim Cramer Says That Amgen’s Stock “Did Not Deserve to Get Hit This Hard”
Share this via
Full Coverage
Jim Cramer Calls Marvell’s Recent Sell Rating “Ridiculous”
Jim Cramer Calls Marvell’s Recent Sell Rating “Ridiculous”
Share this via
Full Coverage
First
Prev.
495
496
497
498
499
500
501
Next
Last
Trending
1.
Joann's closing
2.
Texas Tech basketball
3.
UNC basketball
4.
Monster Hunter Wilds
5.
Ketamine
6.
Macron
7.
UPMC Memorial shooting
8.
Eagles
9.
Hims stock
10.
Joel Embiid
Popular News
BrightGene präsentiert positive Phase-2-Daten für den Dual-G...
3 weeks ago
24
BrightGene präsentiert positive Phase-2-Daten für den Dual-GLP-1R/GIPR-Agonisten zur Gewichtsregulat...
Share this via
The mortgage market hopes for rate cuts amid war moves
3 weeks ago
22
The mortgage market hopes for rate cuts amid war moves
Share this via
Ukraine returns bodies of 3 Russian soldiers repatriated as ...
3 weeks ago
20
Ukraine returns bodies of 3 Russian soldiers repatriated as remains of Ukrainians, Interior Ministry...
Share this via
BrightGene presenteert positieve fase 2 gegevens voor de dua...
3 weeks ago
20
BrightGene presenteert positieve fase 2 gegevens voor de duale GLP-1R/GIPR agonist voor gewichtsbehe...
Share this via
BrightGene présente des données positives de phase 2 pour so...
3 weeks ago
18
BrightGene présente des données positives de phase 2 pour son agoniste double GLP-1R/GIPR dans la ge...
Share this via